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•  Atrial fibrillation (AF) is the most common 
persistent cardiac arrhythmia with an 
increasing incidence in the United States (US)
•  AF is present in 12-15% patients presenting 
with STEMI
•  Previous reports have suggested that STEMI 
patients who have AF have worse outcomes.
•  We sought to determine the impact of AF on in-hospital outcomes of patients admitted with 
STEMI in the United States 
•  Of the total 2,632,447 STEMI hospitalizations, AF was documented in 339,987 (12.9%) 
patients
•  At baseline, patients with AF were older (mean 74 vs 63 years, p<0.001) and more 
likely to be female (42% vs 34%, p<0.001) or white (85% vs78%; p<0.001).  (Table 1)
•  Hypertension, chronic renal failure, diabetes mellitus and congestive heart failure were 
all more prevalent among those with AF (p<0.001 for all).  (Table 1)
•  AF patients were less likely to undergo coronary angiography or any coronary 
revascularization than non-AF patients. They were more likely to undergo CABG but 
less likely to undergo PCI.
•  Patients with AF had higher risk adjusted in- hospital mortality (16.3% vs 7.9%; OR: 
1.16; CI: 1.15-1.18; p<0.001). and an increased risk of bleeding complications after 
both PCI (12.2% vs 5.3%; OR: 1.18; CI: 1.16-1.21; p<0.001) and CABG (40.0% VS 
33.5%; OR: 1.11; CI: 1.08-1.13; p<0.001).  (Table 2)
•  Average length of stay was also longer among those with AF (mean of 7 days vs 4 
days; p<0.001). •  Retrospective design of the study and possibility of varying coding practices among hospitals.
•  Inability to differentiate paroxysmal from persistent or permanent AF.
•  Medication related data are unavailable due to administrative nature of the database
CONCLUSIONS
•  AF is common among patients presenting with STEMI. 
•  AF is associated with older age, and higher prevalence of  comorbidities at admission in STEMI 
patients.
•  AF is independently associated with higher in-hospital mortality, and periprocedural 
complications in STEMI patients.
OBJECTIVE
•  Data were obtained from the Nationwide Inpatient Sample database for years 2003- 2013
•  ICD 9 codes were used to identify patients with STEMI and AF
•  Baseline demographic and clinical features were studied and compared between groups of 
patients with and without AF. 
•  The primary outcome of interest was all-cause in-hospital mortality. 
•  Utilization of percutaneous coronary intervention (PCI) and coronary artery surgery (CABG), and 
the incidences of complications (periprocedural hemorrhage, gastrointestinal bleeding, blood 
transfusion, and acute ischemic stroke) were also compared in the 2 groups.
•  Results are expressed as frequencies (%) for categorical variables and mean ± SD for 
continuous variables. 
•  Differences between groups were analyzed using the Student’s t test for continuous variables 
and the chi-square test for categorical variables.
•  Statistical analyses were performed using IBM SPSS, Statistics, version 20.0 (IBM Corp., 
Armonk, New York).
METHODS
* GI bleed, retroperitoneal hematoma, transfusion or acute anemia.
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Table 1. Baseline Characteristics
Characteristics AF (339,988) Non-AF (2,292,259)
Age 74.4 +/- 12.5 years 63.6 +/- 14.3 years 
Male 196,455 (57.8%)  1,506,360 (65.7%)
White      228,017 (85.3%)       1,391,804 (77.9%)
African American 12,680 (4.7%)  146,865 (8.2%)
Insurance - Medicare 247,890 (73%) 102,4303 (44.8%)
Insurance - Medicaid 10,715 (3.2%) 143,467 (6.3%)
Private 63,246 (18.6%) 837,280 (36.6%)
Obesity 25,089 (7.4%) 222,451 (9.8%)
Hypertension 199,029 (59.1%) 1,312,941 (57.7%)
Diabetes Mellitus 93,338 (27.7%) 613,886 (27%)
Dyslipidemia 131,068 (38.6%) 1,162,491 (50.7%)
Current or Former Smoker 71,638 (21.1%) 874,986 (38.2%)
Prior Myocardial Infarction 25,685 (7.6%) 167,260 (7.3%)
Prior PCI 25,216 (7.4%) 206,090 (9%)
Prior CABG 17,697 (5.2%) 91,920 (4%)
Chronic Kidney Disease 51,047 (15.2%) 177,995 (7.8%)
Chronic Lung Disease 73,306 (21.8%) 355,026 (15.6%)
History of Cerebrovascular Accident 10,529 (3.1%) 39,254 (1.7%)
Peripheral Vascular Disease 32,878 (9.8%) 160,974 (7.1%)
Table 2. Outcomes
Treatment and Outcomes AF Non-AF Adjusted Odds Ratio P-value
Coronary Angiograophy 58.2 % 72.7 % 1.00 (0.98-1.01) .50
Percutaneous Coronary Intervention 41 % 61 % 0.92 (0.91-0.93) <0.001
Coronary Artery Bypass Grafting 15% 7% 2.37 (2.34-2.40) <0.001
All-cause In-hospital Mortality 16.3% 7.9 % 1.16 (1.15-1.18) <0.001
Cardiogenic Shock 14.2% 7.6% 1.27 (1.25-1.28) <0.001
Bleeding Complications (PCI)* 12.2% 5.3% 1.18 (1.16-1.21) <0.001
Bleeding Complications (CABG) 40.0% 33.5% 1.11 (1.08-1.13) <0.001
Acute Ischemic Stroke 1.7% 0.8% 1.4 (1.35-1.44) <0.001
